HRP20040194A2 - GLYCINE-SUBSTITUTED THIENO [2,3-d] PYRIMIDINES WITH COMBINED LH AND FSH AGONISTIC ACTIVITY - Google Patents
GLYCINE-SUBSTITUTED THIENO [2,3-d] PYRIMIDINES WITH COMBINED LH AND FSH AGONISTIC ACTIVITY Download PDFInfo
- Publication number
- HRP20040194A2 HRP20040194A2 HR20040194A HRP20040194A HRP20040194A2 HR P20040194 A2 HRP20040194 A2 HR P20040194A2 HR 20040194 A HR20040194 A HR 20040194A HR P20040194 A HRP20040194 A HR P20040194A HR P20040194 A2 HRP20040194 A2 HR P20040194A2
- Authority
- HR
- Croatia
- Prior art keywords
- amino
- pyrimidine
- thieno
- mixture
- phenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01203328 | 2001-09-04 | ||
| PCT/EP2002/009648 WO2003020727A1 (en) | 2001-09-04 | 2002-08-29 | GLYCINE-SUBSTITUTED THIENO [2,3-d]PYRIMIDINES WITH COMBINED LH AND FSH AGONISTIC ACTIVITY |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20040194A2 true HRP20040194A2 (en) | 2004-08-31 |
Family
ID=8180877
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20040194A HRP20040194A2 (en) | 2001-09-04 | 2002-08-29 | GLYCINE-SUBSTITUTED THIENO [2,3-d] PYRIMIDINES WITH COMBINED LH AND FSH AGONISTIC ACTIVITY |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US7375109B2 (de) |
| EP (1) | EP1427734B1 (de) |
| JP (1) | JP4263094B2 (de) |
| KR (1) | KR100891630B1 (de) |
| CN (1) | CN1261437C (de) |
| AR (1) | AR036408A1 (de) |
| AT (1) | ATE309251T1 (de) |
| AU (1) | AU2002333750B2 (de) |
| BR (1) | BR0212173A (de) |
| CA (1) | CA2457212C (de) |
| CY (1) | CY1106052T1 (de) |
| DE (1) | DE60207280T2 (de) |
| DK (1) | DK1427734T3 (de) |
| EC (1) | ECSP044990A (de) |
| ES (1) | ES2252540T3 (de) |
| HR (1) | HRP20040194A2 (de) |
| HU (1) | HUP0401443A3 (de) |
| IL (2) | IL160194A0 (de) |
| IS (1) | IS2419B (de) |
| MX (1) | MXPA04002046A (de) |
| NO (1) | NO328792B1 (de) |
| NZ (1) | NZ531375A (de) |
| PE (1) | PE20030467A1 (de) |
| PL (1) | PL368388A1 (de) |
| RU (1) | RU2294331C2 (de) |
| WO (1) | WO2003020727A1 (de) |
| ZA (1) | ZA200401459B (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6890923B2 (en) * | 2002-12-16 | 2005-05-10 | Astrazeneca Ab | Compounds |
| KR100666484B1 (ko) * | 2005-02-04 | 2007-01-09 | 삼성전자주식회사 | 반도체 메모리 장치의 입출력 회로 및 입출력 방법 |
| EP2358684B8 (de) | 2008-10-20 | 2014-10-22 | The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services | Schilddrüsen-stimulierende hormon (tsh) rezeptor agonisten mit eringem molekulargewicht |
| CN101762915B (zh) * | 2008-12-24 | 2013-04-17 | 北京京东方光电科技有限公司 | Tft-lcd阵列基板及其驱动方法 |
| CN102791705B (zh) | 2010-04-08 | 2016-08-03 | 美国政府(由卫生和人类服务部的部长所代表) | 用于tsh受体的反向激动剂和中性拮抗剂 |
| SMT202200255T1 (it) | 2012-09-28 | 2022-07-21 | Takeda Pharmaceuticals Co | Forma cristallina di 1-(4-1-(2,6-difluorobenzil)-5-dimetilamminometil-3-(6-metossipiridazin-3-il)-2,4-diosso-1,2,3,4-tetraidrotieno(2,3-d)-pirimidin-6il)fenil)-3-metossiurea |
| WO2021069711A1 (en) | 2019-10-10 | 2021-04-15 | Myovant Sciences Gmbh | Crystalline forms of n-(4-(1-(2,6-difluorobenzyl)-5- ((dimethylamino)methyl)-3-(6-methoxy-3-pyridazinyl)-2,4-dioxo- 1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl)phenyl)-n'- methoxyurea |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19975054I2 (de) | 1987-08-08 | 2000-04-13 | Akzo Nobel Nv | Kontrazeptives Implantat |
| DE19632423A1 (de) * | 1996-08-12 | 1998-02-19 | Merck Patent Gmbh | Thienopyrimidine |
| TW564247B (en) * | 1999-04-08 | 2003-12-01 | Akzo Nobel Nv | Bicyclic heteraromatic compound |
-
2002
- 2002-08-29 EP EP02797646A patent/EP1427734B1/de not_active Expired - Lifetime
- 2002-08-29 AU AU2002333750A patent/AU2002333750B2/en not_active Ceased
- 2002-08-29 HR HR20040194A patent/HRP20040194A2/hr not_active Application Discontinuation
- 2002-08-29 CA CA2457212A patent/CA2457212C/en not_active Expired - Fee Related
- 2002-08-29 DE DE60207280T patent/DE60207280T2/de not_active Expired - Lifetime
- 2002-08-29 CN CNB02817240XA patent/CN1261437C/zh not_active Expired - Fee Related
- 2002-08-29 US US10/488,483 patent/US7375109B2/en not_active Expired - Lifetime
- 2002-08-29 WO PCT/EP2002/009648 patent/WO2003020727A1/en not_active Ceased
- 2002-08-29 BR BR0212173-5A patent/BR0212173A/pt not_active IP Right Cessation
- 2002-08-29 JP JP2003524997A patent/JP4263094B2/ja not_active Expired - Fee Related
- 2002-08-29 DK DK02797646T patent/DK1427734T3/da active
- 2002-08-29 IL IL16019402A patent/IL160194A0/xx unknown
- 2002-08-29 AT AT02797646T patent/ATE309251T1/de not_active IP Right Cessation
- 2002-08-29 RU RU2004110036/04A patent/RU2294331C2/ru not_active IP Right Cessation
- 2002-08-29 HU HU0401443A patent/HUP0401443A3/hu unknown
- 2002-08-29 ES ES02797646T patent/ES2252540T3/es not_active Expired - Lifetime
- 2002-08-29 MX MXPA04002046A patent/MXPA04002046A/es active IP Right Grant
- 2002-08-29 KR KR1020047003096A patent/KR100891630B1/ko not_active Expired - Fee Related
- 2002-08-29 NZ NZ531375A patent/NZ531375A/en not_active IP Right Cessation
- 2002-08-29 PL PL02368388A patent/PL368388A1/xx not_active Application Discontinuation
- 2002-09-02 AR ARP020103310A patent/AR036408A1/es unknown
- 2002-09-03 PE PE2002000839A patent/PE20030467A1/es not_active Application Discontinuation
-
2004
- 2004-02-03 IL IL160194A patent/IL160194A/en not_active IP Right Cessation
- 2004-02-13 IS IS7152A patent/IS2419B/is unknown
- 2004-02-23 ZA ZA200401459A patent/ZA200401459B/en unknown
- 2004-02-26 EC EC2004004990A patent/ECSP044990A/es unknown
- 2004-03-03 NO NO20040922A patent/NO328792B1/no not_active IP Right Cessation
-
2005
- 2005-12-22 CY CY20051101587T patent/CY1106052T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6569863B1 (en) | Bicyclic heteroamatic compounds useful as LH agonists | |
| AU2002337035B2 (en) | Thieno[2,3-d]pyrimidines with combined LH and FSH agonistic activity | |
| AU2002337035A1 (en) | Thieno[2,3-d]pyrimidines with combined LH and FSH agonistic activity | |
| EP1322651B1 (de) | Bicyclische heteroaromatische verbindungen | |
| HRP20040194A2 (en) | GLYCINE-SUBSTITUTED THIENO [2,3-d] PYRIMIDINES WITH COMBINED LH AND FSH AGONISTIC ACTIVITY | |
| AU2002333750A1 (en) | Glycine-substituted thieno[2,3-d]pyrimidines with combined LH and FSH agonistic activity | |
| TWI314861B (en) | Glycine-substituted thieno [2,3-d] pyrimidines with combined lh and fsh agonistic activity | |
| HK1054942B (en) | Bicyclic heteroaromatic compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A1OB | Publication of a patent application | ||
| ARAI | Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application | ||
| PPPP | Transfer of rights |
Owner name: N.V. ORGANON, NL |
|
| ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20090803 Year of fee payment: 8 |
|
| OBST | Application withdrawn |